Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.
(Incorporated in the Cayman Islands with limited liability)
(Stock code: 0690)
This announcement is made pursuant to Rule 17.06A of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the "Listing Rules").
The board of directors of Uni-Bio Science Group Limited (the "Company") hereby announces that on 27 January 2016, share options (the "Options") in respect of 22,000,000 ordinary shares of the Company (the "Shares") were granted to eligible grantees under the share option scheme adopted by the Company on 22 September 2006 (the 10% general limit under the said share option scheme was refreshed pursuant to a resolution passed at the annual general meeting of the Company held on 29 August 2014). The followings are the details of the Options granted:
Date of grant : 27 January 2016 Number of Options granted : 22,000,000
Exercise price of Options granted : HK$0.172 per Share
Closing price of the Shares on the date of grant
: HK$0.172 per Share
The average closing price of the Shares for the five business days immediately preceding the date of grant
: HK$0.145 per Share
Validity period of the Options : From 27 January 2016 to 26 January 2026
Vesting period of the Options : (i) 7,400,000 Options are vested immediately on 27 January 2016;
7,400,000 Options will be vested on 27 January 2017;
7,200,000 Options will be vested on 27 January 2018.
* For identification purpose only
None of the Grantees is a Director, chief executive or Substantial Shareholder, or their respective associates (as defined in the Listing Rules).
By Order of the Board of
Uni-Bio Science Group Limited Tong Kit ShingChairman
Hong Kong, 27 January 2016
As at the date of this announcement, the Board comprises two executive Directors, namely, Mr. TONG Kit Shing (Chairman) and Mr. Kingsley LEUNG; and three independent non-executive Directors, namely, Mr. TSAO Hoi Ho, Terry, Dr. Carl Aslan Jason Morton FIRTH and Mr. ZHAO Zhi Gang.
Uni-Bio Science Group Ltd. issued this content on 27 January 2016 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 29 January 2016 21:14:35 UTC
Original Document: http://www.uni-bioscience.com/ufiles/Grant_Sh_Opt_27012016.pdf
